In a 24-year-old man with recurrent proximal lower‑limb weakness causing difficulty gripping slippers and rising from a squat, prior episodes fully responsive to steroids but a current steroid‑resistant relapse, and no cranial nerve, sensory, or cerebellar involvement, what is the appropriate diagnostic work‑up and acute management?

Recurrent Steroid-Resistant Proximal Myopathy: Diagnostic Work-up and Management

This 24-year-old man with recurrent proximal lower limb weakness now showing steroid resistance requires urgent comprehensive evaluation for inflammatory myopathy with immediate measurement of CK, inflammatory markers (ESR, CRP), troponin, autoimmune myositis panel, EMG, MRI of proximal lower limbs, and consideration of muscle biopsy, followed by escalation to high-dose IV methylprednisolone (1-2 mg/kg) or addition of IVIG/plasmapheresis if no improvement occurs.

Critical Diagnostic Work-up

The steroid-resistant nature of this current episode fundamentally changes the diagnostic and therapeutic approach. While previous episodes responded to steroids, the current resistance suggests either disease progression or an alternative/overlapping diagnosis.

Immediate Laboratory Evaluation

Essential blood tests 1:

• CK, AST, ALT, LDH, aldolase - to quantify muscle inflammation severity
• Troponin and ECG - critical to exclude myocardial involvement (which would mandate permanent treatment escalation)
• ESR and CRP - inflammatory markers
• Comprehensive autoimmune myositis panel - including anti-Jo-1, anti-SRP, anti-HMGCR, anti-Mi-2
• Serum electrolytes - particularly potassium, as hypokalemic periodic paralysis can mimic inflammatory myopathy 2

Neurophysiological and Imaging Studies

EMG with nerve conduction studies 1:

• Distinguishes myopathic from neurogenic patterns
• Rules out neuromuscular junction disorders (myasthenia gravis)
• Identifies demyelinating vs axonal neuropathy patterns

MRI of proximal lower limbs 1:

• Demonstrates muscle edema and inflammation distribution
• Guides optimal biopsy site selection
• Establishes baseline for treatment monitoring

Muscle Biopsy Consideration

Strongly indicated given steroid resistance 1:

• Differentiates inflammatory myopathy subtypes
• Identifies necrotizing myopathy (which requires more aggressive immunosuppression) 3
• Rules out inclusion body myositis (typically steroid-resistant) 4
• Detects vasculitic changes 5

Acute Management Algorithm

Step 1: Assess Severity and Cardiac Risk

If severe weakness (difficulty with mobility, respiratory symptoms, dysphagia) or elevated troponin 1:

• Hospitalize immediately
• Initiate methylprednisolone 1-2 mg/kg IV daily (or higher-dose pulse if severely compromised)
• Cardiac monitoring with echocardiogram
• Respiratory function assessment

If moderate weakness without cardiac involvement 1:

• May start with prednisone 1 mg/kg PO daily
• Close outpatient monitoring with urgent rheumatology/neurology referral

Step 2: Escalation for Steroid-Resistant Disease

Since current episode is already steroid-resistant, consider immediate addition of 1:

First-line steroid-sparing agents:

• IVIG 2 g/kg over 5 days (0.4 g/kg/day) - particularly effective in necrotizing myopathy 3
• Plasmapheresis - alternative to IVIG, especially if IVIG unavailable

Second-line immunosuppressants (if no improvement after 4-6 weeks) 1:

• Methotrexate or azathioprine or mycophenolate mofetil
• Screen for hepatitis B, C, and TB before initiating DMARDs 1

Step 3: Rule Out Alternative Diagnoses

Critical differentials requiring specific management:

Guillain-Barré syndrome 6:

• Ascending weakness with areflexia
• CSF showing albuminocytologic dissociation
• Requires IVIG or plasmapheresis, NOT steroids alone

Myasthenia gravis 1:

• Fatigable weakness, ptosis, diplopia
• Acetylcholine receptor antibodies
• Requires pyridostigmine ± steroids ± IVIG

Post-infectious myositis 7:

• Recent viral illness (1-4 weeks prior)
• Normal or mildly elevated CK
• Elevated IL-6, CRP, ESR
• Usually steroid-responsive, but this patient's resistance argues against this

Hypokalemic periodic paralysis 2:

• Check potassium during weakness episodes
• May present with recurrent proximal weakness
• Requires potassium supplementation, not steroids

Monitoring Strategy

Weekly during acute phase 1:

• CK, ESR, CRP levels
• Clinical strength assessment
• Respiratory function if any respiratory symptoms

Red flags requiring immediate escalation:

• Rising troponin or new cardiac symptoms
• Respiratory muscle weakness (vital capacity decline)
• Worsening despite 4 weeks of treatment

Common Pitfalls to Avoid

1. Assuming all recurrent proximal weakness is the same diagnosis - steroid resistance suggests evolution or alternative pathology
2. Delaying muscle biopsy - critical for guiding immunosuppression in steroid-resistant cases
3. Missing cardiac involvement - check troponin in ALL cases; myocarditis dramatically changes prognosis and treatment
4. Inadequate immunosuppression - steroid-resistant inflammatory myopathy often requires combination therapy from the outset
5. Not screening for infections before DMARDs - hepatitis B reactivation and TB can be fatal 1

Key Distinction from Previous Episodes

The steroid resistance in this episode is the critical feature. While the provided guidelines [1-1] focus on immune checkpoint inhibitor-related myositis, the diagnostic and escalation principles apply directly to idiopathic inflammatory myopathy. The most recent research on steroid-resistant myopathy 7, 3 emphasizes early aggressive immunosuppression with IVIG or additional immunosuppressants rather than continuing steroids alone.